Skip to main content

Exchange-traded transparency

Lyxor has launched London's first exchange-traded note, which unlike its US counterparts is fully collateralised to minimise counterparty risk. But is there a downside to collateralisation? And just how transparent are exchange-traded products when it comes to counterparty risk? John Ferry reports

When Lyxor, the fund management subsidiary of French bank Société Générale and a leading provider of exchange-traded funds (ETFs), decided it wanted to list a product that would give European investors exposure to the price of gold, it faced two problems. First, the Ucits III regulations that govern the European fund market prohibit linkage to a single commodity. The answer? Wrap the product as an

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here